MedPath

Testing the Implementation of Movement-to-Music in a Community Fitness Center and Blended Onsite and Teleexercise Class

Not Applicable
Withdrawn
Conditions
Exercise
Disability Physical
Interventions
Other: Y-M2M©
Other: B-M2M©
Registration Number
NCT03991273
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

To prepare for a large scale-up study, the goal of this pilot implementation trial is to examine the feasibility of Movement-to-Music (M2M©) delivery mechanisms through two channels: 1) a group-based M2M© program conducted onsite at a local YMCA; and 2) a blended program that provides Y-M2M© and a home-based M2M© (B-M2M©) via videoconferencing. A key element of this pilot is to examine issues associated with participant-provider interactions, and to better understand the robustness of the technology to deliver a group-based (teleexercise) version of M2M© in the home setting.

Detailed Description

There will be 4 phases to this study. In phase 1, the investigators will explore potential barriers and supports that may affect the delivery of M2M© at one YMCA facility through one-on-one interviews with YMCA staff that have been trained to conduct M2M©.

Phase 2 will include a quantitative monitoring phase. During this phase the 2 delivery mechanisms of M2M© (Y-M2M© and B-M2M©) will be evaluated through assessments of quantitative feasibility metrics before, during, and after the intervention. The intervention will include a convenient sample of 54 participants.

To expand on the findings from the previous quantitative phase, phase 3 will include post-intervention focus group interviews conducted separately for each stakeholder group: all 54 participants, M2M© trainers, research assistants involved with technical support, and YMCA staff that were involved with the project.

During phase 4 (the integrative phase), the researchers will compile the quantitative and qualitative findings for the three primary feasibility metrics (process, resource, and management). These findings will then be comprehensively analyzed by a review panel that will provide suggestions for improvement within each metric. The panel will then discuss the summative findings and vote towards acceptable or not acceptable feasibility.

The 12-week Y-M2M© intervention will be pilot tested at one YMCA facility in Birmingham, AL.The B-M2M© group will be provided with the flexibility of attending the same onsite classes at the YMCA facility as participants in the Y-M2M© group and will also be able to participate in group M2M© teleexercise classes at home that are conducted through Internet video conferencing.

The investigators will use a permuted block randomization design to ensure close balance between the arms across waves and to increase the unpredictability in the upcoming assignment and prevent inadvertent bias. The project statistician will generate the randomization list that will be provided to the project coordinator in sealed envelopes to conceal the allocation. Assessors (health and function assessments done at Lakeshore Foundation) will be blinded to participant assignment and allocation of the arm assignment will not be done until baseline testing and measures are collected.

Primary quantitative outcomes will include those related to process, resources, and management. In summary, these metrics will include measures of adherence, issues that arise with implementation and the efficiency to which they are resolved, and intervention fidelity between the delivery sites. Secondary quantitative outcomes will include estimates of variability in scientific outcomes (physical activity; quality of life; social participation; fitness Measures (cardiorespiratory fitness, muscle strength, lower extremity function; social cognitive theory constructs \[Self-efficacy, Outcome expectations, Barriers, Social support\]).

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. primary diagnosis of head injury, stroke, MS, spinal cord injury, spina bifida, Parkinson's disease or cerebral palsy conferred by a physician and fits one of the three functional mobility groups (Groups I-III);
  2. between the ages of 19 to 70 yrs.;
  3. physician clearance to participate;
  4. willing to participate in an exercise program 3 times per week;
  5. conversant in and reads English.
Read More
Exclusion Criteria
  1. participated in a similar intervention in the last 6 months;
  2. use of tobacco products in the last 6 months;
  3. cognitive impairment;
  4. active pressure ulcer;
  5. any contraindications to exercise based on the American College of Sports Medicine (ACSM) guidelines;
  6. visual acuity that prevents following a group exercise class;
  7. significant hearing impairment impeding ability to hear music to engage in exercise.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
B-M2M©Y-M2M©a blended program that provides Y-M2M© and a home-based M2M© via videoconferencing
B-M2M©B-M2M©a blended program that provides Y-M2M© and a home-based M2M© via videoconferencing
Y-M2M©Y-M2M©a group-based M2M© program conducted onsite at a local YMCA
Primary Outcome Measures
NameTimeMethod
Phase 2: Quantitative feasibility metric (Process outcome #4: Time to complete data collection)Intervention (weeks 1-12)

Time to complete data collection: time in minutes required to complete data collection (average of both pre- and post-data collection visit times)

Phase 2: Quantitative feasibility metric (Process outcome #1: Technical difficulties with technology)Intervention (weeks 1-12)

Technical difficulties with technology: Frequency of issues experienced by participants and trainers

Phase 2: Quantitative feasibility metric (Management outcome #2: Issues with data management)Intervention (weeks 1-12)

Issues with data management: frequency of issues encountered

Phase 3: Qualitative interview exploring stakeholders' perceptions of intervention implementationPost-Intervention (week 13)

Focus group interviews will be conducted separately for each stakeholder group: all 54 participants, M2M© trainers, research assistants involved with technical support, and YMCA staff that were involved with the project. The semi-structured interviews will explore participants' perceptions regarding the intervention implementation process, resources, and management (using open-ended questions)

Phase 2: Quantitative feasibility metric (Process outcome #3: Attrition Rate)Intervention (weeks 1-12)

Attrition rate: number of participants that withdraw from the intervention

Phase 1: Foreseeable implementation barriers and supports as reported by YMCA trainersPre-intervention (week 0)

Prior to conducting the intervention, the investigators will conduct interviews to qualitatively explore YMCA trainers' perceptions of organizational or system factors that can potentially facilitate the adoption of M2M© in YMCAs and tailor the M2M© delivery plan accordingly (using open-ended questions).

Phase 2: Quantitative feasibility metric (Process outcome #2: Class Attendance)Intervention (weeks 1-12)

Attendance to the exercise sessions: total number of sessions attended divided by the total 36 prescribed sessions

Phase 2: Quantitative feasibility metric (Process outcome #1:Enrollment Rate)Intervention (weeks 1-12)

Enrollment rate: the number of participants screened / total enrolled

Phase 2: Quantitative feasibility metric (Resource outcome #2: Resources required by the YMCA)Intervention (weeks 1-12)

Resources required by the YMCA: # of items purchased for a YMCA M2M class

Phase 2: Quantitative feasibility metric (Management outcome #1: M2M fidelity between conditions)Intervention (weeks 1-12)

M2M fidelity between conditions: the frequency of times a deviation from the protocol was observed for both the YMCA and Teleexercise classes.

Secondary Outcome Measures
NameTimeMethod
Phase 2: Quantitative feasibility metric (Scientific outcome #2: Quality of life)Intervention (weeks 1 and 12)

Quality of life: measured via the NIH PROMIS 10 Global Health Items (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 5: Outcome expectations)Intervention (weeks 1 and 12)

Outcome expectations: measured via the Multidimensional Outcomes Expectations for Exercise Scale (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 7: Social support)Intervention (weeks 1 and 12)

Social support: measured via the Social Provision Scale (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 10: Lower extremity function)Intervention (weeks 1 and 12)

Lower extremity function: measured via the Short Physical Performance Battery (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome #1: Physical Activity)Intervention (weeks 1 and 12)

Physical Activity: measured via the Godin Leisure-Time Exercise Questionnaire (total score and health-contribution score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 8: Cardiorespiratory fitness)Intervention (weeks 1 and 12)

Cardiorespiratory fitness: peak oxygen consumption (ml.kg-1.min-1)

Phase 2: Quantitative feasibility metric (Scientific outcome # 9: Hand-grip strength)Intervention (weeks 1 and 12)

Cardiorespiratory fitness: peak hand-grip strength (Newtons; both hands)

Phase 2: Quantitative feasibility metric (Scientific outcome #3: Social participation)Intervention (weeks 1 and 12)

Social participation: measured via the NIH PROMIS Ability to Participate in Social Roles and Activities

Phase 2: Quantitative feasibility metric (Scientific outcome # 4: Self-Efficacy)Intervention (weeks 1 and 12)

Self-Efficacy: measured via the Exercise Self-Efficacy Scale (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 6: Barriers)Intervention (weeks 1 and 12)

Barriers to physical activity: measured via the Barriers in Physical Activity Questionnaire (total score)

Phase 2: Quantitative feasibility metric (Scientific outcome # 11: Lower extremity function)Intervention (weeks 1 and 12)

Lower extremity function: measured via the Timed Up and Go (total score)

© Copyright 2025. All Rights Reserved by MedPath